MedPath

The effect of Nyvasha spray on cesarean wound healing

Phase 3
Conditions
Cesarean.
Disruption of caesarean section wound
Registration Number
IRCT2017043033716N1
Lead Sponsor
Ethics committee of Mashhad University of Medical Scienes
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Inclusion criteria include: Patient's consent to participate in this study; have minimum level of literacy; Iranian; term pregnancy (37-42 weeks); 18 to 35 years of age; cesarean with beneath cut; initial cesarean section; body mass index in the range of 18.5-25 in early pregnancy; no complications of pregnancy (eclampsia, preclampsia , corioamniotitis, twin pregnancy, poly hydroamnios ); no acute or chronic illness; no-disruptive healing (disease i.e diabetes, kidney disease, anemia, liver disease, mental; not having any abnormality in the fetus ; non-consumption of drugs and tobacco; non-use of drugs affecting wound healing (glucocorticoids, anticoagulants, immunosuppressant drugs and chemotherapy). Exclusion criteria include: Unwillingness to continue cooperation; major bleeding or need for blood transfusion, hysterectomy and myomectomy with cesarean section; prolonged operation for more than 60 minutes; wound infection; irregular spray use and as directed; complications arising from the use of spray; infancy in NICU.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wound healing. Timepoint: After cesarean section (24 ±4 hours) and 5th and 10th days after the caesarian section. Method of measurement: Reeda Scale.
Secondary Outcome Measures
NameTimeMethod
Pain. Timepoint: After cesarean section (24 ±4 hours) and 5th and 10th days after the caesarian section. Method of measurement: Pain visual analog scale.
© Copyright 2025. All Rights Reserved by MedPath